Results 121 to 130 of about 1,293 (183)

Evolution of drug-binding residues in bacterial ribosomes

Ekemezie CL, Chan LI, Brown CR, Helena-Bueno K, Williams TA, Melnikov SV.   +5 more
europepmc   +1 more source

Molecular typing and antimicrobial susceptibility profiles of Campylobacter jejuni and Campylobacter coli Isolates from Patients and raw meat in Huzhou, China, 2021-2022. [PDF]

PLoS One
Wu X, Liping C, Dong F, Yan W, Shen Y, Ji L.   +5 more
europepmc   +1 more source

Six-Year Prescription Pattern of Antimicrobial Use in Cats at the Veterinary Teaching Hospital of the University of Pisa. [PDF]

Animals (Basel)
De Marchi L, Vernaccini M, Meucci V, Briganti A, Lippi I, Marchetti V, Intorre L.   +6 more
europepmc   +1 more source

Addressing urgent priorities in antibiotic development: insights from WHO 2023 antibacterial clinical pipeline analyses.

Lancet Microbe
Melchiorri D, Rocke T, Alm RA, Cameron AM, Gigante V.   +4 more
europepmc   +1 more source

The Paradox of Healthcare in the 'Superbugs' Era: Current Challenges and Future Directions. [PDF]

Pathogens
Sole E, Trinchera M, De Gaetano S, Midiri A, Piccolo G, Mancuso G, Schepici G, Biondo C.   +7 more
europepmc   +1 more source

Prevalence, antibiotic resistance, resistance and virulence determinants of Campylobacter jejuni in China: A systematic review and meta-analysis. [PDF]

One Health
Li Z, Cai H, Xu B, Dong Q, Jia K, Lin Z, Wang X, Liu Y, Qin X.   +8 more
europepmc   +1 more source

Postoperative Empyema Due to Leclercia adecarboxylata Following Mesothelioma Surgery: A Case Report. [PDF]

Pathogens
Montenegro JF, Diaz-Diaz MÁ, Vidal-Cañas S, Urriago G, Correa V, Melo-Burbano LÁ, Liscano Y.   +6 more
europepmc   +1 more source

A Convergent Approach to Resorcinolic Macrolides to Expand Structural Diversity. [PDF]

Chemistry
Lombera JMM, Feng X, Shu X, Seiple IB.
europepmc   +1 more source

Ketolides – The Modern Relatives of Macrolides [PDF]

Clinical Pharmacokinetics, 2009
As with other widely used antibacterials, the abundant use of macrolides for management of ambulant infections has promoted emergence of resistance against them. Ketolides are structurally related to macrolides and were developed to overcome macrolide resistance, while sharing pharmacodynamic and pharmacokinetic characteristics.
Zeitlinger, M, Wagner, C C, Heinisch, B
openaire   +4 more sources

[Macrolides and ketolides]. [PDF]

Enfermedades infecciosas y microbiologia clinica, 2010
Macrolides and ketolides are two families of antibiotics that share the same mechanism of action. They bind to different bases of the peptidyl transferase center of 23S RNA. The antibacterial spectrum of these drugs virtually overlaps, but dissimilarities in the affinity and number of binding sites results in differences in the intensity of their ...
Nazaret, Cobos-Trigueros, Oier, Ateka, Cristina, Pitart, Jordi, Vila   +3 more
core   +4 more sources